CAMBRIDGE, Mass. (AP) _ InVivo Therapeutics Holdings Corp. (NVIV) on Thursday reported a loss of $3.2 million in its third quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 42 cents.
In the final minutes of trading on Thursday, the company's shares hit $2.09. A year ago, they were trading at $31.25.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NVIV at https://www.zacks.com/ap/NVIV